INS and type 1 diabetes mellitus: Nakamura, R: A pilot study to evaluate the safety and feasibility of autologous tolerogenic dendritic cells loaded with proinsulin peptide (C19-A3) in patients with type 1 diabetes; https://clinicaltrials.gov/ct2/show/NCT04590872.